HCPCS Level IIdrugActive
J1442
Inj filgrastim excl biosimil
BETOS: O1E
Effective: 2016-01-01
Referenced in 2 policies
Description
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Neupogen
Manufacturer
Amgen Inc
HCPCS Dosage
1 MCG
Billing Units
480.0000
6
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.